Correlation between IL 2, IL21 and IFNAR1 in Patients with Multiple Sclerosis and Healthy Controls
Main Article Content
Abstract
Regarding the duration of multiple sclerosis and patients divided into two groups ≤ 5 years and > 5 years, the largest number of diseases was (≤ 5years), high significance differences at (P ≤ 0.01). The MS patients were distributed according to EDSS which ranged between (≤ 3) and (> 3) high significance differences at (P ≤ 0.01), the patients were 61 (87.14%). The current study reported that serum level of IL-2 revealed high significant differences at (P ≤ 0.01), (1013.14 ± 391.95 vs. 267.2318 ± 207.76) pg/ml) for patients and controls respectively. Measurement of IFNAR serum level show high significant decrease (791.613 ± 544.066 vs. 1352.995 ± 491.284) pg/ml for patients and controls respectively. While the serum level of IL-21 noted that no significant deference at (P ≤ 0.05) of 70 MS patients (104.851± 268.660 pg/ml) compared with healthy controls of 50 were (68.214± 9.054pg/ml). Regarding, correlation between all study markers WBC types and Interleukins (IL-2, IL-21 and IFNAR) of patients group were explained, positive correlation is observed between Neutrophil and IL21(0.285) at (0.05) level, and positive correlation between Eosinophil and IL-21 and IFNAR (0.241* and 0.270*), respectively. While there was a strong negative relationship between IL-2 and IFNAR which high significant deference correlation (-0.366) at (0.01) level.